1	Frederick	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	(	_	_	_	_	_	_	_	_
3	businessman	_	_	_	_	_	_	_	_
4	)	_	_	_	_	_	_	_	_


1	Frederick	_	_	_	_	_	_	_	_
2	Frank	_	_	_	_	_	_	_	_
3	(	_	_	_	_	_	_	_	_
4	born	_	_	_	_	_	_	_	_
5	May	_	_	_	_	_	_	_	_
6	31	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	1932	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	Salt	_	_	_	_	_	_	_	_
11	Lake	_	_	_	_	_	_	_	_
12	City	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	Utah	_	_	_	_	_	_	_	_
15	)	_	_	_	_	_	_	_	_
16	is	_	_	_	_	_	_	_	_
17	an	_	_	_	_	_	_	_	_
18	investment	_	_	_	_	_	_	_	_
19	banker	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	with	_	_	_	_	_	_	_	_
22	more	_	_	_	_	_	_	_	_
23	than	_	_	_	_	_	_	_	_
24	50	_	_	_	_	_	_	_	_
25	years	_	_	_	_	_	_	_	_
26	of	_	_	_	_	_	_	_	_
27	experience	_	_	_	_	_	_	_	_
28	on	_	_	_	_	_	_	_	_
29	Wall	_	_	_	_	_	_	_	_
30	Street	_	_	_	_	_	_	_	_
31	.	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	is	_	_	_	_	_	_	_	_
3	considered	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	first	_	_	_	_	_	_	_	_
6	investment	_	_	_	_	_	_	_	_
7	banker	_	_	_	_	_	_	_	_
8	to	_	_	_	_	_	_	_	_
9	have	_	_	_	_	_	_	_	_
10	specialized	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	the	_	_	_	_	_	_	_	_
13	areas	_	_	_	_	_	_	_	_
14	of	_	_	_	_	_	_	_	_
15	biotechnology	_	_	_	_	_	_	_	_
16	,	_	_	_	_	_	_	_	_
17	pharmaceuticals	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	and	_	_	_	_	_	_	_	_
20	health	_	_	_	_	_	_	_	_
21	care	_	_	_	_	_	_	_	_
22	services	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	[	_	_	_	_	_	_	_	_
25	4	_	_	_	_	_	_	_	_
26	]	_	_	_	_	_	_	_	_
27	[	_	_	_	_	_	_	_	_
28	5	_	_	_	_	_	_	_	_
29	]	_	_	_	_	_	_	_	_


1	As	_	_	_	_	_	_	_	_
2	of	_	_	_	_	_	_	_	_
3	2014	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	Frank	_	_	_	_	_	_	_	_
6	became	_	_	_	_	_	_	_	_
7	a	_	_	_	_	_	_	_	_
8	founder	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	chair	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	EVOLUTION	_	_	_	_	_	_	_	_
13	Life	_	_	_	_	_	_	_	_
14	Science	_	_	_	_	_	_	_	_
15	Partners	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	previously	_	_	_	_	_	_	_	_
3	served	_	_	_	_	_	_	_	_
4	as	_	_	_	_	_	_	_	_
5	vice	_	_	_	_	_	_	_	_
6	chairman	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	Lehman	_	_	_	_	_	_	_	_
9	Brothers	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	Barclays	_	_	_	_	_	_	_	_
12	Capital	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	and	_	_	_	_	_	_	_	_
15	the	_	_	_	_	_	_	_	_
16	Peter	_	_	_	_	_	_	_	_
17	J.	_	_	_	_	_	_	_	_
18	Solomon	_	_	_	_	_	_	_	_
19	Company	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	[	_	_	_	_	_	_	_	_
22	4	_	_	_	_	_	_	_	_
23	]	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	is	_	_	_	_	_	_	_	_
3	credited	_	_	_	_	_	_	_	_
4	as	_	_	_	_	_	_	_	_
5	lead	_	_	_	_	_	_	_	_
6	underwriter	_	_	_	_	_	_	_	_
7	for	_	_	_	_	_	_	_	_
8	over	_	_	_	_	_	_	_	_
9	125	_	_	_	_	_	_	_	_
10	IPOs	_	_	_	_	_	_	_	_
11	and	_	_	_	_	_	_	_	_
12	as	_	_	_	_	_	_	_	_
13	a	_	_	_	_	_	_	_	_
14	negotiator	_	_	_	_	_	_	_	_
15	in	_	_	_	_	_	_	_	_
16	over	_	_	_	_	_	_	_	_
17	75	_	_	_	_	_	_	_	_
18	mergers	_	_	_	_	_	_	_	_
19	and	_	_	_	_	_	_	_	_
20	acquisitions	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	[	_	_	_	_	_	_	_	_
23	6	_	_	_	_	_	_	_	_
24	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	was	_	_	_	_	_	_	_	_
3	chosen	_	_	_	_	_	_	_	_
4	as	_	_	_	_	_	_	_	_
5	one	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	top	_	_	_	_	_	_	_	_
9	100	_	_	_	_	_	_	_	_
10	contributors	_	_	_	_	_	_	_	_
11	to	_	_	_	_	_	_	_	_
12	biotechnology	_	_	_	_	_	_	_	_
13	in	_	_	_	_	_	_	_	_
14	2005	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	[	_	_	_	_	_	_	_	_
17	5	_	_	_	_	_	_	_	_
18	]	_	_	_	_	_	_	_	_
19	[	_	_	_	_	_	_	_	_
20	7	_	_	_	_	_	_	_	_
21	]	_	_	_	_	_	_	_	_


1	Early	_	_	_	_	_	_	_	_
2	life	_	_	_	_	_	_	_	_
3	and	_	_	_	_	_	_	_	_
4	education	_	_	_	_	_	_	_	_


1	Frederick	_	_	_	_	_	_	_	_
2	Frank	_	_	_	_	_	_	_	_
3	was	_	_	_	_	_	_	_	_
4	born	_	_	_	_	_	_	_	_
5	on	_	_	_	_	_	_	_	_
6	May	_	_	_	_	_	_	_	_
7	31	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	1932	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	[	_	_	_	_	_	_	_	_
12	8	_	_	_	_	_	_	_	_
13	]	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	_
15	Simon	_	_	_	_	_	_	_	_
16	Frank	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	Suzanne	_	_	_	_	_	_	_	_
19	(	_	_	_	_	_	_	_	_
20	Seller	_	_	_	_	_	_	_	_
21	)	_	_	_	_	_	_	_	_
22	Frank	_	_	_	_	_	_	_	_
23	of	_	_	_	_	_	_	_	_
24	Salt	_	_	_	_	_	_	_	_
25	Lake	_	_	_	_	_	_	_	_
26	City	_	_	_	_	_	_	_	_
27	,	_	_	_	_	_	_	_	_
28	Utah	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	ran	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	men	_	_	_	_	_	_	_	_
5	's	_	_	_	_	_	_	_	_
6	wear	_	_	_	_	_	_	_	_
7	business	_	_	_	_	_	_	_	_
8	established	_	_	_	_	_	_	_	_
9	by	_	_	_	_	_	_	_	_
10	his	_	_	_	_	_	_	_	_
11	father	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	Arthur	_	_	_	_	_	_	_	_
14	Frank	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	[	_	_	_	_	_	_	_	_
17	9	_	_	_	_	_	_	_	_
18	]	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	completed	_	_	_	_	_	_	_	_
3	high	_	_	_	_	_	_	_	_
4	school	_	_	_	_	_	_	_	_
5	at	_	_	_	_	_	_	_	_
6	Hotchkiss	_	_	_	_	_	_	_	_
7	School	_	_	_	_	_	_	_	_
8	in	_	_	_	_	_	_	_	_
9	Lakeville	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	Connecticut	_	_	_	_	_	_	_	_
12	in	_	_	_	_	_	_	_	_
13	1950	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	[	_	_	_	_	_	_	_	_
16	8	_	_	_	_	_	_	_	_
17	]	_	_	_	_	_	_	_	_
18	[	_	_	_	_	_	_	_	_
19	10	_	_	_	_	_	_	_	_
20	]	_	_	_	_	_	_	_	_
21	[	_	_	_	_	_	_	_	_
22	3	_	_	_	_	_	_	_	_
23	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	graduated	_	_	_	_	_	_	_	_
3	in	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	class	_	_	_	_	_	_	_	_
6	of	_	_	_	_	_	_	_	_
7	1954	_	_	_	_	_	_	_	_
8	from	_	_	_	_	_	_	_	_
9	Yale	_	_	_	_	_	_	_	_
10	University	_	_	_	_	_	_	_	_
11	with	_	_	_	_	_	_	_	_
12	a	_	_	_	_	_	_	_	_
13	degree	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	philosophy	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_
17	[	_	_	_	_	_	_	_	_
18	11	_	_	_	_	_	_	_	_
19	]	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	served	_	_	_	_	_	_	_	_
3	in	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	U.S.	_	_	_	_	_	_	_	_
6	Army	_	_	_	_	_	_	_	_
7	in	_	_	_	_	_	_	_	_
8	Europe	_	_	_	_	_	_	_	_
9	from	_	_	_	_	_	_	_	_
10	1954-1956	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	much	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	time	_	_	_	_	_	_	_	_
16	in	_	_	_	_	_	_	_	_
17	Paris	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	France	_	_	_	_	_	_	_	_
20	at	_	_	_	_	_	_	_	_
21	Supreme	_	_	_	_	_	_	_	_
22	Headquarters	_	_	_	_	_	_	_	_
23	Allied	_	_	_	_	_	_	_	_
24	Powers	_	_	_	_	_	_	_	_
25	Europe	_	_	_	_	_	_	_	_
26	(	_	_	_	_	_	_	_	_
27	SHAPE	_	_	_	_	_	_	_	_
28	)	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_
30	[	_	_	_	_	_	_	_	_
31	8	_	_	_	_	_	_	_	_
32	]	_	_	_	_	_	_	_	_


1	After	_	_	_	_	_	_	_	_
2	returning	_	_	_	_	_	_	_	_
3	to	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	United	_	_	_	_	_	_	_	_
6	States	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	he	_	_	_	_	_	_	_	_
9	received	_	_	_	_	_	_	_	_
10	an	_	_	_	_	_	_	_	_
11	MBA	_	_	_	_	_	_	_	_
12	from	_	_	_	_	_	_	_	_
13	Stanford	_	_	_	_	_	_	_	_
14	Graduate	_	_	_	_	_	_	_	_
15	School	_	_	_	_	_	_	_	_
16	of	_	_	_	_	_	_	_	_
17	Business	_	_	_	_	_	_	_	_
18	in	_	_	_	_	_	_	_	_
19	1958	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	[	_	_	_	_	_	_	_	_
22	10	_	_	_	_	_	_	_	_
23	]	_	_	_	_	_	_	_	_
24	[	_	_	_	_	_	_	_	_
25	12	_	_	_	_	_	_	_	_
26	]	_	_	_	_	_	_	_	_


1	Career	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	1958	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	Frank	_	_	_	_	_	_	_	_
5	joined	_	_	_	_	_	_	_	_
6	Smith	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	Barney	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	Company	_	_	_	_	_	_	_	_
11	.	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	chose	_	_	_	_	_	_	_	_
3	to	_	_	_	_	_	_	_	_
4	accept	_	_	_	_	_	_	_	_
5	their	_	_	_	_	_	_	_	_
6	offer	_	_	_	_	_	_	_	_
7	because	_	_	_	_	_	_	_	_
8	they	_	_	_	_	_	_	_	_
9	had	_	_	_	_	_	_	_	_
10	a	_	_	_	_	_	_	_	_
11	highly	_	_	_	_	_	_	_	_
12	ranked	_	_	_	_	_	_	_	_
13	research	_	_	_	_	_	_	_	_
14	department	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_


1	After	_	_	_	_	_	_	_	_
2	completing	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	required	_	_	_	_	_	_	_	_
5	formal	_	_	_	_	_	_	_	_
6	training	_	_	_	_	_	_	_	_
7	program	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	Frank	_	_	_	_	_	_	_	_
10	joined	_	_	_	_	_	_	_	_
11	the	_	_	_	_	_	_	_	_
12	research	_	_	_	_	_	_	_	_
13	department	_	_	_	_	_	_	_	_
14	to	_	_	_	_	_	_	_	_
15	work	_	_	_	_	_	_	_	_
16	with	_	_	_	_	_	_	_	_
17	Bill	_	_	_	_	_	_	_	_
18	Grant	_	_	_	_	_	_	_	_
19	on	_	_	_	_	_	_	_	_
20	the	_	_	_	_	_	_	_	_
21	pharmaceutical	_	_	_	_	_	_	_	_
22	and	_	_	_	_	_	_	_	_
23	chemical	_	_	_	_	_	_	_	_
24	industries	_	_	_	_	_	_	_	_
25	.	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	soon	_	_	_	_	_	_	_	_
3	proposed	_	_	_	_	_	_	_	_
4	splitting	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	two	_	_	_	_	_	_	_	_
7	areas	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	became	_	_	_	_	_	_	_	_
11	Wall	_	_	_	_	_	_	_	_
12	Street	_	_	_	_	_	_	_	_
13	â€™s	_	_	_	_	_	_	_	_
14	first	_	_	_	_	_	_	_	_
15	industry	_	_	_	_	_	_	_	_
16	analyst	_	_	_	_	_	_	_	_
17	dedicated	_	_	_	_	_	_	_	_
18	to	_	_	_	_	_	_	_	_
19	pharmaceuticals	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	1962	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	he	_	_	_	_	_	_	_	_
5	shifted	_	_	_	_	_	_	_	_
6	focus	_	_	_	_	_	_	_	_
7	to	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	life	_	_	_	_	_	_	_	_
10	sciences	_	_	_	_	_	_	_	_
11	industries	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	dealing	_	_	_	_	_	_	_	_
14	with	_	_	_	_	_	_	_	_
15	medical	_	_	_	_	_	_	_	_
16	devices	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	diagnostics	_	_	_	_	_	_	_	_
19	companies	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	and	_	_	_	_	_	_	_	_
22	healthcare	_	_	_	_	_	_	_	_
23	services	_	_	_	_	_	_	_	_
24	.	_	_	_	_	_	_	_	_
25	[	_	_	_	_	_	_	_	_
26	12	_	_	_	_	_	_	_	_
27	]	_	_	_	_	_	_	_	_


1	He	_	_	_	_	_	_	_	_
2	held	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	positions	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	co-leader	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	research	_	_	_	_	_	_	_	_
9	,	_	_	_	_	_	_	_	_
10	vice	_	_	_	_	_	_	_	_
11	president	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	and	_	_	_	_	_	_	_	_
14	director	_	_	_	_	_	_	_	_
15	at	_	_	_	_	_	_	_	_
16	Smith	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	Barney	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_
20	[	_	_	_	_	_	_	_	_
21	5	_	_	_	_	_	_	_	_
22	]	_	_	_	_	_	_	_	_
23	[	_	_	_	_	_	_	_	_
24	12	_	_	_	_	_	_	_	_
25	]	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	October	_	_	_	_	_	_	_	_
3	1969	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	Frank	_	_	_	_	_	_	_	_
6	left	_	_	_	_	_	_	_	_
7	Smith	_	_	_	_	_	_	_	_
8	Barney	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	joined	_	_	_	_	_	_	_	_
11	Lehman	_	_	_	_	_	_	_	_
12	Brothers	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	first	_	_	_	_	_	_	_	_
16	person	_	_	_	_	_	_	_	_
17	from	_	_	_	_	_	_	_	_
18	outside	_	_	_	_	_	_	_	_
19	the	_	_	_	_	_	_	_	_
20	organization	_	_	_	_	_	_	_	_
21	to	_	_	_	_	_	_	_	_
22	join	_	_	_	_	_	_	_	_
23	it	_	_	_	_	_	_	_	_
24	at	_	_	_	_	_	_	_	_
25	the	_	_	_	_	_	_	_	_
26	level	_	_	_	_	_	_	_	_
27	of	_	_	_	_	_	_	_	_
28	partner	_	_	_	_	_	_	_	_
29	.	_	_	_	_	_	_	_	_


1	Leaving	_	_	_	_	_	_	_	_
2	research	_	_	_	_	_	_	_	_
3	and	_	_	_	_	_	_	_	_
4	analysis	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	he	_	_	_	_	_	_	_	_
7	shifted	_	_	_	_	_	_	_	_
8	to	_	_	_	_	_	_	_	_
9	investment	_	_	_	_	_	_	_	_
10	banking	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	handling	_	_	_	_	_	_	_	_
13	capital	_	_	_	_	_	_	_	_
14	investment	_	_	_	_	_	_	_	_
15	and	_	_	_	_	_	_	_	_
16	mergers	_	_	_	_	_	_	_	_
17	and	_	_	_	_	_	_	_	_
18	acquisitions	_	_	_	_	_	_	_	_
19	.	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	is	_	_	_	_	_	_	_	_
3	credited	_	_	_	_	_	_	_	_
4	with	_	_	_	_	_	_	_	_
5	creating	_	_	_	_	_	_	_	_
6	original	_	_	_	_	_	_	_	_
7	and	_	_	_	_	_	_	_	_
8	at	_	_	_	_	_	_	_	_
9	times	_	_	_	_	_	_	_	_
10	unprecedented	_	_	_	_	_	_	_	_
11	structures	_	_	_	_	_	_	_	_
12	that	_	_	_	_	_	_	_	_
13	have	_	_	_	_	_	_	_	_
14	connected	_	_	_	_	_	_	_	_
15	innovative	_	_	_	_	_	_	_	_
16	early-stage	_	_	_	_	_	_	_	_
17	research-oriented	_	_	_	_	_	_	_	_
18	companies	_	_	_	_	_	_	_	_
19	with	_	_	_	_	_	_	_	_
20	larger	_	_	_	_	_	_	_	_
21	development	_	_	_	_	_	_	_	_
22	and	_	_	_	_	_	_	_	_
23	market-oriented	_	_	_	_	_	_	_	_
24	pharmaceutical	_	_	_	_	_	_	_	_
25	corporations	_	_	_	_	_	_	_	_
26	.	_	_	_	_	_	_	_	_
27	[	_	_	_	_	_	_	_	_
28	12	_	_	_	_	_	_	_	_
29	]	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	1978	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	Frank	_	_	_	_	_	_	_	_
5	led	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	team	_	_	_	_	_	_	_	_
8	at	_	_	_	_	_	_	_	_
9	Lehman	_	_	_	_	_	_	_	_
10	Brothers	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	handling	_	_	_	_	_	_	_	_
13	Humana	_	_	_	_	_	_	_	_
14	'	_	_	_	_	_	_	_	_
15	s	_	_	_	_	_	_	_	_
16	acquisition	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	American	_	_	_	_	_	_	_	_
19	Medicorp	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_


1	The	_	_	_	_	_	_	_	_
2	team	_	_	_	_	_	_	_	_
3	included	_	_	_	_	_	_	_	_
4	Mary	_	_	_	_	_	_	_	_
5	Catherine	_	_	_	_	_	_	_	_
6	Tanner	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	recent	_	_	_	_	_	_	_	_
10	graduate	_	_	_	_	_	_	_	_
11	from	_	_	_	_	_	_	_	_
12	Harvard	_	_	_	_	_	_	_	_
13	University	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	[	_	_	_	_	_	_	_	_
16	12	_	_	_	_	_	_	_	_
17	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	convinced	_	_	_	_	_	_	_	_
3	her	_	_	_	_	_	_	_	_
4	to	_	_	_	_	_	_	_	_
5	join	_	_	_	_	_	_	_	_
6	his	_	_	_	_	_	_	_	_
7	team	_	_	_	_	_	_	_	_
8	at	_	_	_	_	_	_	_	_
9	Lehman	_	_	_	_	_	_	_	_
10	.	_	_	_	_	_	_	_	_


1	Ten	_	_	_	_	_	_	_	_
2	years	_	_	_	_	_	_	_	_
3	later	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	on	_	_	_	_	_	_	_	_
6	October	_	_	_	_	_	_	_	_
7	15	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	1988	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	they	_	_	_	_	_	_	_	_
12	were	_	_	_	_	_	_	_	_
13	married	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	[	_	_	_	_	_	_	_	_
16	3	_	_	_	_	_	_	_	_
17	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	vice	_	_	_	_	_	_	_	_
4	chair	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	Lehman	_	_	_	_	_	_	_	_
7	Brothers	_	_	_	_	_	_	_	_
8	in	_	_	_	_	_	_	_	_
9	1995	_	_	_	_	_	_	_	_
10	.	_	_	_	_	_	_	_	_
11	[	_	_	_	_	_	_	_	_
12	11	_	_	_	_	_	_	_	_
13	]	_	_	_	_	_	_	_	_


1	Tanner	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	senior	_	_	_	_	_	_	_	_
4	managing	_	_	_	_	_	_	_	_
5	director	_	_	_	_	_	_	_	_
6	.	_	_	_	_	_	_	_	_
7	[	_	_	_	_	_	_	_	_
8	1	_	_	_	_	_	_	_	_
9	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	and	_	_	_	_	_	_	_	_
3	Tanner	_	_	_	_	_	_	_	_
4	worked	_	_	_	_	_	_	_	_
5	together	_	_	_	_	_	_	_	_
6	at	_	_	_	_	_	_	_	_
7	Lehman	_	_	_	_	_	_	_	_
8	for	_	_	_	_	_	_	_	_
9	over	_	_	_	_	_	_	_	_
10	ten	_	_	_	_	_	_	_	_
11	years	_	_	_	_	_	_	_	_
12	,	_	_	_	_	_	_	_	_
13	until	_	_	_	_	_	_	_	_
14	Tanner	_	_	_	_	_	_	_	_
15	took	_	_	_	_	_	_	_	_
16	time	_	_	_	_	_	_	_	_
17	off	_	_	_	_	_	_	_	_
18	to	_	_	_	_	_	_	_	_
19	have	_	_	_	_	_	_	_	_
20	a	_	_	_	_	_	_	_	_
21	child	_	_	_	_	_	_	_	_
22	.	_	_	_	_	_	_	_	_
23	[	_	_	_	_	_	_	_	_
24	2	_	_	_	_	_	_	_	_
25	]	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	the	_	_	_	_	_	_	_	_
3	late	_	_	_	_	_	_	_	_
4	1970s	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	Frank	_	_	_	_	_	_	_	_
7	began	_	_	_	_	_	_	_	_
8	to	_	_	_	_	_	_	_	_
9	work	_	_	_	_	_	_	_	_
10	with	_	_	_	_	_	_	_	_
11	companies	_	_	_	_	_	_	_	_
12	such	_	_	_	_	_	_	_	_
13	as	_	_	_	_	_	_	_	_
14	Cetus	_	_	_	_	_	_	_	_
15	,	_	_	_	_	_	_	_	_
16	a	_	_	_	_	_	_	_	_
17	company	_	_	_	_	_	_	_	_
18	developing	_	_	_	_	_	_	_	_
19	industrial	_	_	_	_	_	_	_	_
20	applications	_	_	_	_	_	_	_	_
21	for	_	_	_	_	_	_	_	_
22	Recombinant	_	_	_	_	_	_	_	_
23	DNA	_	_	_	_	_	_	_	_
24	technology	_	_	_	_	_	_	_	_
25	,	_	_	_	_	_	_	_	_
26	and	_	_	_	_	_	_	_	_
27	Genentech	_	_	_	_	_	_	_	_
28	.	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	saw	_	_	_	_	_	_	_	_
3	rDNA	_	_	_	_	_	_	_	_
4	technology	_	_	_	_	_	_	_	_
5	as	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	"	_	_	_	_	_	_	_	_
8	game-changing	_	_	_	_	_	_	_	_
9	opportunity	_	_	_	_	_	_	_	_
10	"	_	_	_	_	_	_	_	_
11	.	_	_	_	_	_	_	_	_
12	[	_	_	_	_	_	_	_	_
13	12	_	_	_	_	_	_	_	_
14	]	_	_	_	_	_	_	_	_


1	Advised	_	_	_	_	_	_	_	_
2	by	_	_	_	_	_	_	_	_
3	Frank	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	Cetus	_	_	_	_	_	_	_	_
6	went	_	_	_	_	_	_	_	_
7	public	_	_	_	_	_	_	_	_
8	on	_	_	_	_	_	_	_	_
9	March	_	_	_	_	_	_	_	_
10	1	_	_	_	_	_	_	_	_
11	,	_	_	_	_	_	_	_	_
12	1981	_	_	_	_	_	_	_	_
13	with	_	_	_	_	_	_	_	_
14	the	_	_	_	_	_	_	_	_
15	second-largest	_	_	_	_	_	_	_	_
16	IPO	_	_	_	_	_	_	_	_
17	in	_	_	_	_	_	_	_	_
18	U.S.	_	_	_	_	_	_	_	_
19	corporate	_	_	_	_	_	_	_	_
20	history	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	[	_	_	_	_	_	_	_	_
23	12	_	_	_	_	_	_	_	_
24	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	was	_	_	_	_	_	_	_	_
3	also	_	_	_	_	_	_	_	_
4	instrumental	_	_	_	_	_	_	_	_
5	in	_	_	_	_	_	_	_	_
6	the	_	_	_	_	_	_	_	_
7	Bristol-Myers	_	_	_	_	_	_	_	_
8	Squibb	_	_	_	_	_	_	_	_
9	merger	_	_	_	_	_	_	_	_
10	of	_	_	_	_	_	_	_	_
11	1989	_	_	_	_	_	_	_	_
12	and	_	_	_	_	_	_	_	_
13	the	_	_	_	_	_	_	_	_
14	Hoffmann-La	_	_	_	_	_	_	_	_
15	Roche	_	_	_	_	_	_	_	_
16	acquisition	_	_	_	_	_	_	_	_
17	of	_	_	_	_	_	_	_	_
18	Genentech	_	_	_	_	_	_	_	_
19	in	_	_	_	_	_	_	_	_
20	1990	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	[	_	_	_	_	_	_	_	_
23	12	_	_	_	_	_	_	_	_
24	]	_	_	_	_	_	_	_	_


1	At	_	_	_	_	_	_	_	_
2	the	_	_	_	_	_	_	_	_
3	time	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	merger	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	an	_	_	_	_	_	_	_	_
9	established	_	_	_	_	_	_	_	_
10	pharmaceutical	_	_	_	_	_	_	_	_
11	company	_	_	_	_	_	_	_	_
12	with	_	_	_	_	_	_	_	_
13	a	_	_	_	_	_	_	_	_
14	younger	_	_	_	_	_	_	_	_
15	biotechnology	_	_	_	_	_	_	_	_
16	company	_	_	_	_	_	_	_	_
17	was	_	_	_	_	_	_	_	_
18	highly	_	_	_	_	_	_	_	_
19	unusual	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_


1	It	_	_	_	_	_	_	_	_
2	has	_	_	_	_	_	_	_	_
3	been	_	_	_	_	_	_	_	_
4	described	_	_	_	_	_	_	_	_
5	by	_	_	_	_	_	_	_	_
6	Frank	_	_	_	_	_	_	_	_
7	as	_	_	_	_	_	_	_	_
8	a	_	_	_	_	_	_	_	_
9	"	_	_	_	_	_	_	_	_
10	strategy	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	convergence	_	_	_	_	_	_	_	_
13	"	_	_	_	_	_	_	_	_
14	.	_	_	_	_	_	_	_	_
15	[	_	_	_	_	_	_	_	_
16	13	_	_	_	_	_	_	_	_
17	]	_	_	_	_	_	_	_	_


1	After	_	_	_	_	_	_	_	_
2	Barclays	_	_	_	_	_	_	_	_
3	Capital	_	_	_	_	_	_	_	_
4	bought	_	_	_	_	_	_	_	_
5	Lehman	_	_	_	_	_	_	_	_
6	's	_	_	_	_	_	_	_	_
7	U.S.	_	_	_	_	_	_	_	_
8	capital	_	_	_	_	_	_	_	_
9	markets	_	_	_	_	_	_	_	_
10	unit	_	_	_	_	_	_	_	_
11	in	_	_	_	_	_	_	_	_
12	September	_	_	_	_	_	_	_	_
13	2008	_	_	_	_	_	_	_	_
14	,	_	_	_	_	_	_	_	_
15	[	_	_	_	_	_	_	_	_
16	14	_	_	_	_	_	_	_	_
17	]	_	_	_	_	_	_	_	_
18	[	_	_	_	_	_	_	_	_
19	15	_	_	_	_	_	_	_	_
20	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	vice	_	_	_	_	_	_	_	_
5	chair	_	_	_	_	_	_	_	_
6	at	_	_	_	_	_	_	_	_
7	Barclays	_	_	_	_	_	_	_	_
8	Capital	_	_	_	_	_	_	_	_
9	.	_	_	_	_	_	_	_	_
10	[	_	_	_	_	_	_	_	_
11	16	_	_	_	_	_	_	_	_
12	]	_	_	_	_	_	_	_	_


1	As	_	_	_	_	_	_	_	_
2	of	_	_	_	_	_	_	_	_
3	March	_	_	_	_	_	_	_	_
4	18	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	2009	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	Frederick	_	_	_	_	_	_	_	_
9	Frank	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	Mary	_	_	_	_	_	_	_	_
12	Tanner	_	_	_	_	_	_	_	_
13	joined	_	_	_	_	_	_	_	_
14	Peter	_	_	_	_	_	_	_	_
15	J.	_	_	_	_	_	_	_	_
16	Solomon	_	_	_	_	_	_	_	_
17	,	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	PJ	_	_	_	_	_	_	_	_
20	SOLOMON	_	_	_	_	_	_	_	_
21	to	_	_	_	_	_	_	_	_
22	form	_	_	_	_	_	_	_	_
23	a	_	_	_	_	_	_	_	_
24	new	_	_	_	_	_	_	_	_
25	practice	_	_	_	_	_	_	_	_
26	focusing	_	_	_	_	_	_	_	_
27	on	_	_	_	_	_	_	_	_
28	pharmaceuticals	_	_	_	_	_	_	_	_
29	and	_	_	_	_	_	_	_	_
30	life	_	_	_	_	_	_	_	_
31	sciences	_	_	_	_	_	_	_	_
32	.	_	_	_	_	_	_	_	_
33	[	_	_	_	_	_	_	_	_
34	16	_	_	_	_	_	_	_	_
35	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	a	_	_	_	_	_	_	_	_
4	vice	_	_	_	_	_	_	_	_
5	chairman	_	_	_	_	_	_	_	_
6	at	_	_	_	_	_	_	_	_
7	Peter	_	_	_	_	_	_	_	_
8	J.	_	_	_	_	_	_	_	_
9	Solomon	_	_	_	_	_	_	_	_
10	,	_	_	_	_	_	_	_	_
11	while	_	_	_	_	_	_	_	_
12	Tanner	_	_	_	_	_	_	_	_
13	became	_	_	_	_	_	_	_	_
14	a	_	_	_	_	_	_	_	_
15	managing	_	_	_	_	_	_	_	_
16	director	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	[	_	_	_	_	_	_	_	_
19	17	_	_	_	_	_	_	_	_
20	]	_	_	_	_	_	_	_	_


1	As	_	_	_	_	_	_	_	_
2	of	_	_	_	_	_	_	_	_
3	January	_	_	_	_	_	_	_	_
4	15	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	2013	_	_	_	_	_	_	_	_
7	,	_	_	_	_	_	_	_	_
8	Frederick	_	_	_	_	_	_	_	_
9	Frank	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	Mary	_	_	_	_	_	_	_	_
12	Tanner	_	_	_	_	_	_	_	_
13	joined	_	_	_	_	_	_	_	_
14	Burrill	_	_	_	_	_	_	_	_
15	&	_	_	_	_	_	_	_	_
16	Company	_	_	_	_	_	_	_	_
17	.	_	_	_	_	_	_	_	_
18	[	_	_	_	_	_	_	_	_
19	18	_	_	_	_	_	_	_	_
20	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	chair	_	_	_	_	_	_	_	_
4	of	_	_	_	_	_	_	_	_
5	Burrill	_	_	_	_	_	_	_	_
6	Securities	_	_	_	_	_	_	_	_
7	(	_	_	_	_	_	_	_	_
8	2013-	_	_	_	_	_	_	_	_
9	)	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	vice	_	_	_	_	_	_	_	_
12	chair	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	Burrill	_	_	_	_	_	_	_	_
15	and	_	_	_	_	_	_	_	_
16	Company	_	_	_	_	_	_	_	_
17	(	_	_	_	_	_	_	_	_
18	January	_	_	_	_	_	_	_	_
19	15	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	2013-	_	_	_	_	_	_	_	_
22	)	_	_	_	_	_	_	_	_
23	.	_	_	_	_	_	_	_	_
24	[	_	_	_	_	_	_	_	_
25	19	_	_	_	_	_	_	_	_
26	]	_	_	_	_	_	_	_	_


1	Tanner	_	_	_	_	_	_	_	_
2	became	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	Senior	_	_	_	_	_	_	_	_
5	Managing	_	_	_	_	_	_	_	_
6	Director	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	Burrill	_	_	_	_	_	_	_	_
9	Securities	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	Burrill	_	_	_	_	_	_	_	_
13	&	_	_	_	_	_	_	_	_
14	Company	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	[	_	_	_	_	_	_	_	_
17	18	_	_	_	_	_	_	_	_
18	]	_	_	_	_	_	_	_	_


1	As	_	_	_	_	_	_	_	_
2	of	_	_	_	_	_	_	_	_
3	2014	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	Frank	_	_	_	_	_	_	_	_
6	and	_	_	_	_	_	_	_	_
7	Tanner	_	_	_	_	_	_	_	_
8	founded	_	_	_	_	_	_	_	_
9	EVOLUTION	_	_	_	_	_	_	_	_
10	Life	_	_	_	_	_	_	_	_
11	Science	_	_	_	_	_	_	_	_
12	Partners	_	_	_	_	_	_	_	_
13	,	_	_	_	_	_	_	_	_
14	and	_	_	_	_	_	_	_	_
15	Frank	_	_	_	_	_	_	_	_
16	became	_	_	_	_	_	_	_	_
17	chair	_	_	_	_	_	_	_	_
18	of	_	_	_	_	_	_	_	_
19	the	_	_	_	_	_	_	_	_
20	company	_	_	_	_	_	_	_	_
21	.	_	_	_	_	_	_	_	_
22	[	_	_	_	_	_	_	_	_
23	4	_	_	_	_	_	_	_	_
24	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	has	_	_	_	_	_	_	_	_
3	also	_	_	_	_	_	_	_	_
4	served	_	_	_	_	_	_	_	_
5	on	_	_	_	_	_	_	_	_
6	numerous	_	_	_	_	_	_	_	_
7	advisory	_	_	_	_	_	_	_	_
8	groups	_	_	_	_	_	_	_	_
9	and	_	_	_	_	_	_	_	_
10	boards	_	_	_	_	_	_	_	_
11	of	_	_	_	_	_	_	_	_
12	directors	_	_	_	_	_	_	_	_
13	.	_	_	_	_	_	_	_	_
14	[	_	_	_	_	_	_	_	_
15	19	_	_	_	_	_	_	_	_
16	]	_	_	_	_	_	_	_	_


1	Philanthropy	_	_	_	_	_	_	_	_


1	As	_	_	_	_	_	_	_	_
2	of	_	_	_	_	_	_	_	_
3	October	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	1997	_	_	_	_	_	_	_	_
6	,	_	_	_	_	_	_	_	_
7	the	_	_	_	_	_	_	_	_
8	non-profit	_	_	_	_	_	_	_	_
9	Tanner	_	_	_	_	_	_	_	_
10	Frank	_	_	_	_	_	_	_	_
11	Foundation	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	New	_	_	_	_	_	_	_	_
14	York	_	_	_	_	_	_	_	_
15	City	_	_	_	_	_	_	_	_
16	was	_	_	_	_	_	_	_	_
17	granted	_	_	_	_	_	_	_	_
18	charitable	_	_	_	_	_	_	_	_
19	status	_	_	_	_	_	_	_	_
20	.	_	_	_	_	_	_	_	_
21	[	_	_	_	_	_	_	_	_
22	20	_	_	_	_	_	_	_	_
23	]	_	_	_	_	_	_	_	_


1	Frank	_	_	_	_	_	_	_	_
2	has	_	_	_	_	_	_	_	_
3	served	_	_	_	_	_	_	_	_
4	on	_	_	_	_	_	_	_	_
5	the	_	_	_	_	_	_	_	_
6	board	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	advisors	_	_	_	_	_	_	_	_
9	of	_	_	_	_	_	_	_	_
10	the	_	_	_	_	_	_	_	_
11	School	_	_	_	_	_	_	_	_
12	of	_	_	_	_	_	_	_	_
13	Management	_	_	_	_	_	_	_	_
14	(	_	_	_	_	_	_	_	_
15	SOM	_	_	_	_	_	_	_	_
16	)	_	_	_	_	_	_	_	_
17	at	_	_	_	_	_	_	_	_
18	Yale	_	_	_	_	_	_	_	_
19	University	_	_	_	_	_	_	_	_
20	,	_	_	_	_	_	_	_	_
21	and	_	_	_	_	_	_	_	_
22	has	_	_	_	_	_	_	_	_
23	given	_	_	_	_	_	_	_	_
24	generously	_	_	_	_	_	_	_	_
25	to	_	_	_	_	_	_	_	_
26	SOM	_	_	_	_	_	_	_	_
27	.	_	_	_	_	_	_	_	_


1	Gifts	_	_	_	_	_	_	_	_
2	include	_	_	_	_	_	_	_	_
3	the	_	_	_	_	_	_	_	_
4	establishment	_	_	_	_	_	_	_	_
5	of	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	language	_	_	_	_	_	_	_	_
8	study	_	_	_	_	_	_	_	_
9	fellowship	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	a	_	_	_	_	_	_	_	_
12	visiting	_	_	_	_	_	_	_	_
13	professorship	_	_	_	_	_	_	_	_
14	in	_	_	_	_	_	_	_	_
15	1998	_	_	_	_	_	_	_	_
16	.	_	_	_	_	_	_	_	_


1	In	_	_	_	_	_	_	_	_
2	2007	_	_	_	_	_	_	_	_
3	,	_	_	_	_	_	_	_	_
4	he	_	_	_	_	_	_	_	_
5	established	_	_	_	_	_	_	_	_
6	a	_	_	_	_	_	_	_	_
7	professorship	_	_	_	_	_	_	_	_
8	,	_	_	_	_	_	_	_	_
9	[	_	_	_	_	_	_	_	_
10	11	_	_	_	_	_	_	_	_
11	]	_	_	_	_	_	_	_	_
12	which	_	_	_	_	_	_	_	_
13	was	_	_	_	_	_	_	_	_
14	first	_	_	_	_	_	_	_	_
15	filled	_	_	_	_	_	_	_	_
16	in	_	_	_	_	_	_	_	_
17	2009	_	_	_	_	_	_	_	_
18	when	_	_	_	_	_	_	_	_
19	Gary	_	_	_	_	_	_	_	_
20	Gorton	_	_	_	_	_	_	_	_
21	became	_	_	_	_	_	_	_	_
22	Yale	_	_	_	_	_	_	_	_
23	's	_	_	_	_	_	_	_	_
24	first	_	_	_	_	_	_	_	_
25	Frederick	_	_	_	_	_	_	_	_
26	Frank	_	_	_	_	_	_	_	_
27	Class	_	_	_	_	_	_	_	_
28	of	_	_	_	_	_	_	_	_
29	1954	_	_	_	_	_	_	_	_
30	Professor	_	_	_	_	_	_	_	_
31	of	_	_	_	_	_	_	_	_
32	Management	_	_	_	_	_	_	_	_
33	and	_	_	_	_	_	_	_	_
34	Finance	_	_	_	_	_	_	_	_
35	.	_	_	_	_	_	_	_	_
36	[	_	_	_	_	_	_	_	_
37	21	_	_	_	_	_	_	_	_
38	]	_	_	_	_	_	_	_	_


1	On	_	_	_	_	_	_	_	_
2	April	_	_	_	_	_	_	_	_
3	9	_	_	_	_	_	_	_	_
4	,	_	_	_	_	_	_	_	_
5	2012	_	_	_	_	_	_	_	_


1	Olav	_	_	_	_	_	_	_	_
2	Sorenson	_	_	_	_	_	_	_	_
3	became	_	_	_	_	_	_	_	_
4	the	_	_	_	_	_	_	_	_
5	inaugural	_	_	_	_	_	_	_	_
6	holder	_	_	_	_	_	_	_	_
7	of	_	_	_	_	_	_	_	_
8	the	_	_	_	_	_	_	_	_
9	Frank	_	_	_	_	_	_	_	_
10	and	_	_	_	_	_	_	_	_
11	Tanner	_	_	_	_	_	_	_	_
12	Professor	_	_	_	_	_	_	_	_
13	of	_	_	_	_	_	_	_	_
14	Management	_	_	_	_	_	_	_	_
15	.	_	_	_	_	_	_	_	_
16	[	_	_	_	_	_	_	_	_
17	22	_	_	_	_	_	_	_	_
18	]	_	_	_	_	_	_	_	_


1	Awards	_	_	_	_	_	_	_	_
2	and	_	_	_	_	_	_	_	_
3	honors	_	_	_	_	_	_	_	_
4	2019	_	_	_	_	_	_	_	_
5	,	_	_	_	_	_	_	_	_
6	Richard	_	_	_	_	_	_	_	_
7	J.	_	_	_	_	_	_	_	_
8	Bolte	_	_	_	_	_	_	_	_
9	Sr.	_	_	_	_	_	_	_	_
10	Award	_	_	_	_	_	_	_	_
11	for	_	_	_	_	_	_	_	_
12	supporting	_	_	_	_	_	_	_	_
13	industries	_	_	_	_	_	_	_	_
14	[	_	_	_	_	_	_	_	_
15	4	_	_	_	_	_	_	_	_
16	]	_	_	_	_	_	_	_	_
17	2006	_	_	_	_	_	_	_	_
18	,	_	_	_	_	_	_	_	_
19	Gilda	_	_	_	_	_	_	_	_
20	's	_	_	_	_	_	_	_	_
21	Club	_	_	_	_	_	_	_	_
22	of	_	_	_	_	_	_	_	_
23	New	_	_	_	_	_	_	_	_
24	York	_	_	_	_	_	_	_	_
25	City	_	_	_	_	_	_	_	_
26	Visionary	_	_	_	_	_	_	_	_
27	Award	_	_	_	_	_	_	_	_
28	[	_	_	_	_	_	_	_	_
29	19	_	_	_	_	_	_	_	_
30	]	_	_	_	_	_	_	_	_
31	2005	_	_	_	_	_	_	_	_
32	,	_	_	_	_	_	_	_	_
33	Top	_	_	_	_	_	_	_	_
34	100	_	_	_	_	_	_	_	_
35	living	_	_	_	_	_	_	_	_
36	contributors	_	_	_	_	_	_	_	_
37	to	_	_	_	_	_	_	_	_
38	biotechnology	_	_	_	_	_	_	_	_
39	,	_	_	_	_	_	_	_	_
40	Reed	_	_	_	_	_	_	_	_
41	Elsevier	_	_	_	_	_	_	_	_
42	[	_	_	_	_	_	_	_	_
43	5	_	_	_	_	_	_	_	_
44	]	_	_	_	_	_	_	_	_
45	2004	_	_	_	_	_	_	_	_
46	,	_	_	_	_	_	_	_	_
47	Albert	_	_	_	_	_	_	_	_
48	Einstein	_	_	_	_	_	_	_	_
49	Award	_	_	_	_	_	_	_	_
50	from	_	_	_	_	_	_	_	_
51	the	_	_	_	_	_	_	_	_
52	Weizmann	_	_	_	_	_	_	_	_
53	Institute	_	_	_	_	_	_	_	_
54	of	_	_	_	_	_	_	_	_
55	Science	_	_	_	_	_	_	_	_
56	[	_	_	_	_	_	_	_	_
57	19	_	_	_	_	_	_	_	_
58	]	_	_	_	_	_	_	_	_
59	1998	_	_	_	_	_	_	_	_
60	,	_	_	_	_	_	_	_	_
61	Outstanding	_	_	_	_	_	_	_	_
62	Contributions	_	_	_	_	_	_	_	_
63	in	_	_	_	_	_	_	_	_
64	the	_	_	_	_	_	_	_	_
65	Field	_	_	_	_	_	_	_	_
66	of	_	_	_	_	_	_	_	_
67	Immunology	_	_	_	_	_	_	_	_
68	,	_	_	_	_	_	_	_	_
69	Irvington	_	_	_	_	_	_	_	_
70	Institute	_	_	_	_	_	_	_	_
71	for	_	_	_	_	_	_	_	_
72	Immunological	_	_	_	_	_	_	_	_
73	Research	_	_	_	_	_	_	_	_
74	[	_	_	_	_	_	_	_	_
75	19	_	_	_	_	_	_	_	_
76	]	_	_	_	_	_	_	_	_
77	[	_	_	_	_	_	_	_	_
78	5	_	_	_	_	_	_	_	_
79	]	_	_	_	_	_	_	_	_
80	1997	_	_	_	_	_	_	_	_
81	,	_	_	_	_	_	_	_	_
82	Hall	_	_	_	_	_	_	_	_
83	of	_	_	_	_	_	_	_	_
84	Fame	_	_	_	_	_	_	_	_
85	Award	_	_	_	_	_	_	_	_
86	,	_	_	_	_	_	_	_	_
87	The	_	_	_	_	_	_	_	_
88	Biotech	_	_	_	_	_	_	_	_
89	Meeting	_	_	_	_	_	_	_	_
90	in	_	_	_	_	_	_	_	_
91	Laguna	_	_	_	_	_	_	_	_
92	Niguel	_	_	_	_	_	_	_	_
93	,	_	_	_	_	_	_	_	_
94	California	_	_	_	_	_	_	_	_
95	.	_	_	_	_	_	_	_	_
96	[	_	_	_	_	_	_	_	_
97	5	_	_	_	_	_	_	_	_
98	]	_	_	_	_	_	_	_	_
99	[	_	_	_	_	_	_	_	_
100	6	_	_	_	_	_	_	_	_
101	]	_	_	_	_	_	_	_	_

